Chlorophyllin treatment reduces benzo[a]pyrene (BP)-induced CYP1A1 and CYP1B1 expression and BP-DNA adduct formation in normal human mammary epithelial cells (NHMECs).
Authors
Keshava C; Divi RL; Whipkey DL; Leonard SL; Poirier MC; Weston A
Source
Proceedings of the American Association for Cancer Research (AACR) 95th Annual Meeting, March 27-31, 2004, Orlando Florida, Abstract 741. Philadelphia, PA: American Association for Cancer Research, 2004 Mar; 46:1
The capacity of cultured NHMECs to activate BP and form BP-DNA adducts has been previously demonstrated. The advantage of these normal breast cells obtained from reduction mammoplasty is that each cell strain reflects the metabolic profile of an individual donor. Recently, we showed wide inter-individual variation in BP-induced CYP1A1 ( 100-fold) and CYP1B1 ( 40-fold) expression in NHMECs. Although levels of CYP1A1 and CYP1B1 induction were highly correlated with each other (r2 = 0.82, p<0.01) neither appeared to be a good predictor of BP-DNA adduct formation (r2 = 0.40 and 0.50, p<0.10 and 0.05, respectively). However, we hypothesized that since the first step in BP activation is dependent on cytochrome p450 (CYP) metabolism, inhibition of CYP induction might result in reduction of BP-DNA adduct formation. In these studies one NHMEC strain was exposed for 24h to 5µM chlorophyllin either before exposure to 4µM BP for 24h, together with BP exposure (4µM for 24h) or both 24h before and during exposure to 4µM BP for 24h. After exposure, CYP1A1 and CYP1B1 gene expression was monitored by Affymetrix DNA oligonucleotide microarrays (U133A) and reverse transcription/quantitative real-time polymerase chain reaction (RT-PCR). In addition, DNA was extracted and BP-DNA adducts were measured using an anti-BP-DNA chemiluminescence immunoassay. The data showed that BP-induced CYP1A1 and CYP1B1 expression was mitigated by all three chlorophyllin treatment regimens, but that maximal inhibition of enzyme induction was obtained with chlorophyllin exposure before and during BP-exposure. Using RT-PCR, the CYP1A1 induction was maximally reduced by >85% (p<0.01) and CYP1B1 induction was reduced by >70% (p<0.01). BP-induced expression of several other genes (STAT1, 1F1TM1 and G1P3) was also reduced by chlorophyllin exposure. BP-DNA adduct formation was concomitantly reduced in direct proportion to the levels of CYP1A1 and CYP1B1 reduction (r2 = 0.90, p<0.01), and the DNA adduct levels were maximally reduced by >85% (p<0.01). These data show that chorophyllin substantially blocks the BP-induction of CYP1A1 and CYP1B1 expression and associated BP-DNA adduct formation in NHMECs.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.